Observational Study October 1, 2026

Blood Marker Linked to Heart Risk May Be Influenced by Omega-3 Levels

General Wellness Heart Health Metabolism

This large study followed over 42,000 adults in the UK Biobank who did not have existing heart disease or heart failure at the start. Researchers measured a blood protein called heart-type fatty acid-binding protein (H-FABP), which is involved in moving fat molecules inside cells and has previously been used as an early marker for heart attacks.

Over time, people with higher H-FABP levels had a notably greater risk of developing coronary heart disease, heart attacks, dying from heart-related causes, and developing heart failure. The associations were consistent and grew stronger for more severe outcomes like cardiac death and heart failure.

The researchers also looked at whether omega-3 fatty acid levels interacted with this risk marker, suggesting that fatty acid status may play a role in how this protein relates to long-term heart outcomes in the general population.

What this means for you

This research highlights a blood marker that may help identify people at higher long-term risk for heart problems, and suggests omega-3 fatty acid status could be a relevant factor to consider alongside it. It does not test or prove that omega-3 supplementation changes this risk, so more targeted research is needed before drawing conclusions about prevention or treatment.

Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.

Start the ALP Protocol

Source

Heart (British Cardiac Society) · 2026-10-01 · DOI: 10.1136/heartjnl-2026-327893

Read the original source ↗

This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.